REQUEST A DEMO
Total
USD $0.00
Search more companies

Duopharma Biotech Berhad (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Duopharma Biotech Berhad Profile Updated: October 31, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English Download a sample report

Ccm Duopharma Biotech Berhad engaged in investment holding. The principal activities of the subsidiary are manufacturing, distributing, importing and exporting of pharmaceutical products and medicines. The company was incorporated in 2000 and is based in Kuala Lumpur.

Legal Address
Lot 2599,Jalan Seruling 59,Kawasan 3, Taman Klang Jaya
Klang; Selangor; Postal Code: 41200

Contact Details: Purchase the Duopharma Biotech Berhad report to view the information.

Website: http://www.duopharmabiotech.com

Basic Information
Total Employees:
Purchase the Duopharma Biotech Berhad report to view the information.
Outstanding Shares:
Purchase the Duopharma Biotech Berhad report to view the information.
Financial Auditors:
Purchase the Duopharma Biotech Berhad report to view the information.
Ratings:
Purchase the Duopharma Biotech Berhad report to view the information.
Incorporation Date:
August 23, 2000
Key Executives
Purchase this report to view the information.
Chief Operating Officer
Ownership Details
Purchase this report to view the information.
46.855%
Subsidiaries
Duopharma (M) Sendirian Berhad
100%
Company Performance
Financial values in the chart are available after Duopharma Biotech Berhad report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
13.29%
Total operating revenue
13.53%
Operating profit (EBIT)
17.23%
EBITDA
16.48%
Net Profit (Loss) for the Period
17.8%
Total assets
18.24%
Total equity
3.01%
Operating Profit Margin (ROS)
0.49%
Net Profit Margin
0.39%
Return on Equity (ROE)
1.02%
Debt to Equity Ratio
21.89%
Quick Ratio
-0.42%
Cash Ratio
-0.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?